2 ASX stocks that could help turn $10,000 into $1 million

I'd think about adding these ASX shares to your portfolio.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Every investor's ultimate goal is to produce huge returns from their ASX stocks. While it's possible to turn $10,000 into $1 million, it's not as simple or as risk-free as you'd expect.

This level of investment growth usually takes many years of strong earnings, a lot of patience, and a big chunk of luck.

But if I had to pick two ASX stocks that I thought could make it happen, it would be these two.

Multi-ethnic people looking at a camera in a public place and screaming, shouting, and feeling overjoyed.

Image source: Getty Images

Pro Medicus Ltd (ASX: PME)

The Pro Medicus share price soared to an all-time high of around $330 per share in July last year. It then seesawed until around early October. At this point, a sudden shift in investor sentiment sent the ASX stock crashing. 

Key drivers were a combination of a broad-based tech sector sell-off, concerns that the company's share price was inflated and overvalued, and investors taking huge profits off the table after a strong run.

Sentiment didn't improve when the company posted a record-breaking half-year FY26 result in mid-February. Its revenue was up 28%, and profit jumped nearly 30%, but it still missed investors' extremely high expectations.

But it's worth noting that despite the confidence crash, as a business, Pro Medicus is incredibly strong. The company is continually expanding operations, and the outlook for the medical imaging sector is positive.

Pro Medicus even made some leaps in company growth over the past couple of months. The business has won several contracts so far in 2026, including two $40 million five-year contract renewals with its wholly owned US subsidiary, Visage Imaging, in early March.

At the time of writing, the shares are up 4.4% to $122.04. But I think the stock is still trading significantly below fair value right now. Analysts tip an upside of up to 145% to $300 per share, at the time of writing.

Megaport Ltd (ASX: MP1)

Megaport is another ASX stock that was caught up in the sector-wide sell-off of technology stocks. At the time, many investors were also concerned that AI could disrupt traditional software models. There was also concern that AI tools might replace or reduce demand for subscription-based software. 

The beaten-down tech stock was also battered by high investor expectations and heavy acquisition spending, which raised concerns about near-term costs and profits. 

Megaport shares climbed to a mult-year high in November last year, before crashing nearly 60% to the price at the time of writing.

But the reality is that the long-term drivers of AI and tech-sector growth haven't gone away. Technology is rapidly advancing, and businesses are investing in AI more than ever before. Continued tech investment points to widespread, ongoing adoption rather than rejection.

At the time of writing, Megaport shares are up 1% to $7.32 a piece. But I think the market will correct itself, and AI-related tech stocks could enjoy a share price recovery. Analysts tip a huge upside of up to 227% to $23.98 over the next 12 months.

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Megaport. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A golden egg with dividend cash flying out of it
Growth Shares

Forget Easter eggs, these ASX shares could be your best buys this month

These shares could be top buys after the Easter break.

Read more »

Two smiling work colleagues discuss an investment at their office.
Growth Shares

3 amazing ASX growth shares I'd buy and hold for the next decade

These shares could be worth holding tightly to for the long term.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Growth Shares

$5,000 invested in Droneshield shares 4 months ago is already worth…

Investors will be thrilled!

Read more »

Person with a handful of Australian dollar notes, symbolising dividends.
Dividend Investing

1 ASX dividend share and 1 ASX growth stock to buy in April

These ASX shares deliver a one-two punch: income now, growth later.

Read more »

Increasing white bar graph with a rising arrow on an orange background.
Growth Shares

Here's what I consider to be the very best ASX 200 share to buy in April

This business looks heavily undervalued to me.

Read more »

Scared people on a rollercoaster holding on for dear life, indicating a plummeting share price
Growth Shares

3 reasons to buy this red-hot ASX healthcare stock today

Brokers think the biotech share is gearing up for its next big move.

Read more »

Part of male mannequin dressed in casual clothes holding a sale paper shopping bag.
Growth Shares

2 ASX financial stocks that could double – or even triple – in value

If sentiment turns and execution delivers, this could be an opportunity investors won’t want to miss.

Read more »

Rising arrows and a 3D chart, indicating a rising share price.
Growth Shares

2 strong Australian stocks to buy now with $8,000

These businesses have a lot of long-term potential.

Read more »